How to Help Your Patients Save Money on Nepafenac: A Provider's Guide to Savings Programs

For ophthalmologists and eye care providers, cost is one of the most common barriers keeping cataract surgery patients from filling their post-operative prescriptions on time. Nepafenac (Nevanac 0.1% or Ilevro 0.3%) retails for $370–$480 without insurance — and even insured patients can face copays of $60–$80 or more.

This guide gives you the specific programs, strategies, and workflows to help your patients access Nepafenac at an affordable cost — so they arrive at surgery day ready to start their post-operative regimen on time.

Understanding the Cost Landscape for Nepafenac

Nepafenac's cost structure is straightforward but impactful:

• Nevanac (0.1%, 3mL): $370–$413 cash price; ~$321–$330 with GoodRx or SingleCare; ~$60–$80 with insurance coverage
• Ilevro (0.3%, 3mL): ~$481 cash; ~$321 with SingleCare; coverage varies by plan
• No generic available: As of January 2026, no FDA-approved generic nepafenac is marketed in the U.S.
• Insurance coverage: ~80% of commercial plans cover Nevanac; PA may be required; Medicare Part D tier placement varies

Savings Tool 1: Harrow Eye Patient Assistance Program

Harrow Eye, the current NDA holder for Nevanac and Ilevro, offers a patient assistance program (PAP) for uninsured or underinsured patients who cannot afford their medication. Key program details:

• Eligible patients may receive the medication at no cost
• Income eligibility: typically below $40,000/year (individual) or $60,000/year (couple)
• Requires valid prescription, proof of income, U.S. residency, and documentation that patient is uninsured or underinsured
• Processing typically takes 2–4 weeks — applicants should apply as early as possible, ideally at the pre-op appointment

Workflow recommendation: Identify uninsured or underinsured patients at the time of surgical scheduling — not at the pre-op appointment. This maximizes the time available to submit and receive approval before surgery day.

Savings Tool 2: GoodRx and SingleCare Coupons

Prescription discount cards provide immediate savings for patients who don't qualify for the PAP or who need the medication quickly. Consider building these into your patient education materials:

• GoodRx: Nevanac ~$321 per 3mL bottle (approximately 13% off retail); varies by pharmacy
• SingleCare: Nevanac from $323; Ilevro from $321 — prices vary by pharmacy location

Discount cards cannot be used together with insurance. Instruct patients to present the coupon to the pharmacist when picking up and ask them to price it as cash. Many patients are surprised that the coupon price is lower than their insurance copay.

Practical tip: Print or display a QR code for GoodRx.com or SingleCare.com in your pre-op education area, or include it in pre-surgical patient paperwork.

Savings Tool 3: Third-Party Patient Assistance Services

Several organizations specialize in helping patients navigate manufacturer PAPs and other savings programs. These can be valuable for patients who struggle with paperwork or who have complex eligibility situations:

• RxAssist (rxassist.org): Free directory of manufacturer PAPs with eligibility details
• NeedyMeds (needymeds.org): Comprehensive PAP database with eligibility screening tool
• Prescription Hope: A managed enrollment service that coordinates PAP applications across multiple medications for a fixed monthly service fee (~$70/month per medication)

Savings Tool 4: Formulary Navigation and Prior Authorization Strategy

For insured patients, the key financial levers are formulary tier placement and prior authorization:

• Check formulary tier status for both Nevanac and Ilevro across your highest-volume payers before each coverage year begins
• For plans requiring PA, submit the authorization at the pre-op visit with the clinical documentation (post-cataract surgery indication, specific formulation need)
• For step therapy requirements, document clearly if there is a clinical reason the generic alternative is not preferred for this patient (corneal disease, prior NSAID intolerance, compliance concerns with QID dosing)
• Track patients who need PA and follow up to confirm approval before their surgical date

Savings Tool 5: Prescribing Cost-Effective Generic Alternatives

When Nepafenac's cost is a barrier that cannot be overcome through assistance programs or coupons, consider whether a generic ophthalmic NSAID is clinically appropriate for the patient. Generic options and approximate costs:

• Generic Bromfenac 0.07% (Prolensa generic): $80–$200; once-daily — best compliance equivalent to Ilevro
• Generic Ketorolac 0.5%: $15–$50; QID — most affordable; suitable for uncomplicated, low-risk cataract patients
• Generic Diclofenac 0.1%: $20–$60; QID — long track record, low cost

When documenting a switch from Nepafenac to a generic for cost reasons, note the clinical rationale and patient consent in the chart. Remind patients of the dosing differences — especially if switching from once-daily Ilevro to QID generic ketorolac, where compliance is the primary clinical concern.

Building a Cost Access Protocol for Your Practice

The practices that have the fewest fill failures build systematic cost access screening into their pre-op workflow:

1. Screen insurance coverage at scheduling (not pre-op): Verify Nepafenac/Ilevro formulary tier and PA requirements at time of surgical scheduling.
2. Initiate PAP for uninsured patients at scheduling: This gives maximum time for the application to be processed before surgery day.
3. Send prescriptions at pre-op visit: All post-op prescriptions go out at the pre-op appointment, 1–2 weeks before surgery.
4. Provide discount card information proactively: Include GoodRx and SingleCare information in pre-surgical patient handouts for self-pay patients.
5. Use medfinder for Providers to locate pharmacies with Nepafenac in stock, and direct high-cost patients to pharmacies where the discount card price is verified.
6. Maintain a small office sample inventory: Bridge patients who can't fill in time with a sample course through surgery and the first post-op days.

Summary: Cost Management Resources at a Glance

• PAP (uninsured/underinsured): Harrow Eye PAP — may provide medication at no cost; contact Harrow directly or through rxassist.org
• Coupon (cash pay): GoodRx / SingleCare — Nevanac ~$321–$330; Ilevro ~$321
• Insurance optimization: Pre-authorization with documented indication; appeal step therapy for appropriate patients
• Generic alternative: Generic Ketorolac $15–$50; Diclofenac $20–$60; Bromfenac $80–$200

The Bottom Line for Providers

Nepafenac's cost is a predictable, manageable problem — but only if your practice builds the tools to address it proactively. Use the Harrow PAP, discount card guidance, formulary management, and generic alternatives as a layered system. For real-time pharmacy availability, medfinder for Providers helps your team identify which pharmacies near each patient currently stock Nepafenac, and can direct cost-sensitive patients to locations with confirmed availability and the lowest local price.